Literature DB >> 11117565

Serum alanine aminotransferase levels in relation to hepatitis B and C virus infections among drug abusers in an area hyperendemic for hepatitis B.

C J Chang1, Y C Ko, H W Liu.   

Abstract

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the major agents responsible for hepatitis in Taiwan. The purpose of this study was to assess the serum alanine aminotransferase (ALT) activity in relation to HBV and HCV infection among drug abusers. This survey included 769 male drug abusers aged 14-59 years, from the Kaohsiung Narcotic Abstention Institute and Kaohsiung Prision. The prevalence of HBsAg seropositivity was 21.5%, and anti-HCV seropositivity was 27.2%, respectively. Drug abusers with HBsAg or anti-HCV had higher serum AST and ALT levels than those without HBsAg and anti-HCV. The prevalence of raised ALT and AST (> or =45 IU/liter) in the HCV-positive group was more significant than in the negative group, while that of the HBsAg-positive group did not reach statistical significance. Among the HCV-positive group, ALT levels are more closely associated with HCV infection than AST levels. Our results indicated that HCV infection plays an important role in the etiology of raised ALT activity among drug abusers, while HBV infection plays a minor role. ALT screening still remains a simple and valuable method in the early recognition of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117565     DOI: 10.1023/a:1005690517074

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  20 in total

1.  Vertical transmission of hepatitis B antigen in Taiwan.

Authors:  C E Stevens; R P Beasley; J Tsui; W C Lee
Journal:  N Engl J Med       Date:  1975-04-10       Impact factor: 91.245

2.  Hepatitis B virus infection in Taiwan with reference to anti-HBc versus HBsAg and anti-HBs.

Authors:  J S Wu; C H Chen; Y H Chiang; Y C Lee; M H Lee; Y C Ko; H T Hu
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1980-09

3.  Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors.

Authors:  J F Tsai; J E Jeng; M S Ho; C S Wang; W Y Chang; M Y Hsieh; Z Y Lin; J H Tsai
Journal:  Liver       Date:  1997-02

4.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay.

Authors:  C L Van der Poel; H T Cuypers; H W Reesink; A J Weiner; S Quan; R Di Nello; J J Van Boven; I Winkel; D Mulder-Folkerts; P J Exel-Oehlers
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

6.  Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.

Authors:  D S Chen; G C Kuo; J L Sung; M Y Lai; J C Sheu; P J Chen; P M Yang; H M Hsu; M H Chang; C J Chen
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

7.  Hepatitis C virus infection in patients infected with the human immunodeficiency virus.

Authors:  C M Quan; M Krajden; G A Grigoriew; I E Salit
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

8.  Longitudinal study of hepatitis C viremia in chronic hepatitis C.

Authors:  R C Cheung; R T Chan; A S Lok
Journal:  J Med Virol       Date:  1993-12       Impact factor: 2.327

9.  Hepatitis C virus infection in Taiwan.

Authors:  D S Chen; J T Wang; P J Chen; T H Wang; J L Sung
Journal:  Gastroenterol Jpn       Date:  1991-07

10.  Hepatitis C virus infection in an HIV-positive population in Normandy: antibodies, HCV RNA and genotype prevalence.

Authors:  I Mendel; L Clotteau; S Lambert; C Buffet-Janvresse
Journal:  J Med Virol       Date:  1995-11       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.